Interprofessional Webinar Series:
Caring for Holocaust Survivors with Sensitivity at the End of Life
This webinar is presented in collaboration with the
National Hospice and Palliative Care Organization.
Funding Disclosure: No commercial funding has been accepted for the activity.
Date and Time: June 2, 2016, 12:30 PM – 1:30 PM ET (Live)
Location: Online at http://www.mjhspalliativeinstitute.org/e-learning/
Speaker Name and Title:
Toby Weiss, MSOD
Director of Cultural Sensitivity and Jewish Programming
MJHS Hospice and Palliative Care
New York, NY
Purpose: The goal of this webinar is to explore the unique needs of Holocaust survivors and to discuss best practices in assessment and intervention within the theoretical framework of PTSD as it impacts advanced illness and end of life.
Why Do I Need to Know This? More than 70 years after the end of World War II, Holocaust Survivors represent a population with unique needs and issues poorly understood by healthcare professionals. Clinicians and professional providers, whose mission it is to manage pain and suffering, need to understand these issues so they can provide culturally sensitive care.
Objectives: Participants will be able to:
- Discuss best practices in developing plan of care when working with holocausts survivors.
- Identify common emotional triggers and their impact on end-of-life care for Holocaust survivors.
- Identify best practices for healthcare providers in working with survivors of the Holocaust, trauma, or war.
- Identify key research findings and learning opportunities from the Holocaust literature.
Target Audience: palliative care specialists, pain specialists, primary care providers, nurse practitioners, registered nurses, advanced practice nurses, registered nurses with a specialty in palliative care/hospice, pharmacists, allied health professionals, fellows, residents, and medical students
Criteria for Successful Completion:
- Attendance at entire session (mandatory for nurses and social workers)
- Submission of completed evaluation form (mandatory to receive CE/CME credit for MDs, nurses, social workers)
- Successful completion of a posttest; 80% passing grade (mandatory to receive CE credit for social workers)
Continuing Education Credits: 1.0
Continuing Education Accreditation:
Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Hospice and Palliative Care Organization (NHPCO) and MJHS. NHPCO is accredited by the ACCME to provide continuing medical education for physicians.
NHPCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: NHPCO is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation.
NHPCO designates this live activity for a maximum of 1.0 contact hour. Nurses should claim only the contact hours commensurate with the extent of their participation in the activity. Accredited status by ANCC refers only to continuing nursing education and does not imply endorsement of any commercial product discussed in conjunction with this activity.
Social Workers: MJHS Institute for Innovation in Palliative Care SW CPE is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #0242.
Please note: This webinar offers New York State (NYS) social work continuing education edits only.
Individual: $25 (includes CME/CE certificate)
Group: $65 + $5 per CME/CE certificate
Registration fees for webinars are not refundable.
System Requirements for Computers and Mobile Devices:
Toby Weiss, MSOD, has no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.
Russell K. Portenoy, MD, Planner, has indicated a relationship with Pfizer Inc. for research grant support.
No other Planning Committee Member has any disclosures.
Planning Committee Members
Barbara Bouton, MA, FT
Colleen Fleming-Damon, PhDc, APRN-BC, ACHPN-BC, C.T.
Steven R. Gardner, MPA, PAHM
Myra Glajchen, DSW
Jennifer Kennedy, RN, MA, BSN, CHC
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Judith A. Skretny